B. Riley Securities initiated coverage on PROCEPT BioRobotics with a new price target

6/23/22 12:21:46 PM ET

Medical/Dental Instruments

Health Care

B. Riley Securities initiated coverage of PROCEPT BioRobotics with a rating of Buy and set a new price target of $53.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PRCT

Date	Price Target	Rating	Analyst
12/2/2024	$105.00	Overweight	Morgan Stanley
11/14/2024	$95.00	Hold	Jefferies
8/11/2023	$42.00	Overweight	Piper Sandler
5/31/2023		Outperform	William Blair
10/31/2022		Neutral	BTIG Research
10/25/2022	$58.00	Buy	Truist
9/2/2022	$49.00	Overweight	Wells Fargo
7/15/2022	$47.00	Overweight	KeyBanc Capital Markets